Table 2.
G6PD deficiency status amongst males and females participants per primary health care clinic according to the CareStart™ G6PD RDT
| CareStart™ G6PDd RDT classificationa | Males (n, %) | Females (n, %) | ||
|---|---|---|---|---|
| Deficient (10, 18%) | Normal (45, 82%) | Deficient (23, 12%)b | Normal (170, 88%)c | |
| Primary health care clinicsa | ||||
| Folovhodwe | 2 (4%) | 8 (14%) | 7 (4%) | 36 (19%) |
| Madimbo | 1 (2%) | 5 (9%) | 1 (0.5%) | 50 (26%) |
| Manenzhe | 1 (2%) | 8 (14%) | 5 (3%) | 33 (17%) |
| Masisi | 2 (4%) | 9 (16%) | 3 (1%) | 22 (11%) |
| Mulala | 2 (4%) | 5 (9%) | 5 (3%) | 6 (3%) |
| Tshipise | 2 (4%) | 10 (18%) | 2 (1%) | 23 (12%) |
aNo of participants and (%) indicated
bFrom the deficient females by CareStart™ G6PD RDT test, 2 were homozygous, 7 heterozygous and 14 normal
cFrom the 170 normal females, 25 were heterozygous and 145 normal